Correlation Between Cardio Diagnostics and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and VistaGen Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and VistaGen Therapeutics.
Diversification Opportunities for Cardio Diagnostics and VistaGen Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cardio and VistaGen is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and VistaGen Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to generate 2.44 times more return on investment than VistaGen Therapeutics. However, Cardio Diagnostics is 2.44 times more volatile than VistaGen Therapeutics. It trades about 0.09 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 4.98 in Cardio Diagnostics Holdings on September 23, 2024 and sell it today you would earn a total of 4.81 from holding Cardio Diagnostics Holdings or generate 96.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 79.07% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. VistaGen Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
VistaGen Therapeutics |
Cardio Diagnostics and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and VistaGen Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.Cardio Diagnostics vs. Cardio Diagnostics Holdings | Cardio Diagnostics vs. Revelation Biosciences | Cardio Diagnostics vs. LMF Acquisition Opportunities | Cardio Diagnostics vs. OmniAb Inc |
VistaGen Therapeutics vs. Fate Therapeutics | VistaGen Therapeutics vs. Sana Biotechnology | VistaGen Therapeutics vs. Caribou Biosciences | VistaGen Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |